The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Knight Therapeutics released the voting results on a variety of the company’s decisions, from the annual meeting of shareholders.
Knight Therapeutics (TSX:GUD) released the voting results on a variety of the company’s decisions, from the annual meeting of shareholders.
As quoted in the press release:
Election of Directors
Each director nominee listed in the Management Information Circular dated March 21, 2017 (“Circular”) was elected as Director of the Corporation at the Meeting. Shareholders present in person or represented by proxy at the Meeting voted as follows:
DIRECTOR NOMINEE OUTCOME VOTES FOR % FOR VOTES WITHHELD % WITHHELD James C. Gale Elected 96,908,864 98.84% 1,135,250 1.16% Dr. Sarit Assouline Elected 97,835,461 99.79% 208,653 0.21% Jonathan Ross Goodman Elected 96,803,831 98.73% 1,240,283 1.27% Meir Jakobsohn Elected 96,097,771 98.01% 1,946,343 1.99% Robert N. Lande Elected 96,885,834 98.82% 1,158,280 1.18% Samira Sakhia Elected 94,108,859 95.99% 3,935,255 4.01% Sylvie Tendler Elected 96,883,334 98.82% 1,160,780 1.18% Adoption of a new stock option plan
The resolution to adopt a new stock option plan of the Corporation, as more particularly described in the Circular, was approved by a majority of the votes cast by the shareholders present or represented by proxy. Shareholders present in person or represented by proxy at the Meeting voted as follows:
VOTES FOR % FOR VOTES AGAINST % AGAINST 91,210,582 93.03% 6,833,532 6.97%
Source: www.marketwired.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.